Board of Directors
Meet the visionary leaders guiding our organization towards growth, innovation, and excellence. Our Board of Directors brings together diverse expertise, strategic thinking, and unwavering commitment to building a stronger future.

Mr. Rajiv R. Modi
Chairman

Mr. Rajiv R. Modi
Chairman
Mr. Rajiv R. Modi is a visionary leader and entrepreneur with extensive knowledge in diverse industries including new age tech ventures.
Mr. Rajiv has joined the Board of Directors of Cadila Group in 2024. His extensive professional journey spans leadership roles in global hospitality, aviation, energy and pharmaceutical sectors, notably at Cadila Group, where he led various divisions and innovation-driven projects.
Academically, he has a diverse educational foundation marked by top-tier achievements in Cambridge Advanced Level and IGCSE. He is also pursuing a Master of Arts (Honours) in Management from the University of St. Andrews. Rajiv brings a unique blend of academic and practical expertise. His commitment also extends to community welfare, demonstrated by cleanliness drives, green initiatives, and hosting global summits.
He is driven by excellence, innovation, and a vision to make meaningful contributions in every venture.

Biswajit Mitra
Whole Time Director

Biswajit Mitra
Whole Time Director
Biswajit Mitra is a seasoned global techno-commercial leader with over 35 years of experience in the life sciences industry, spanning Pharma Formulations, Active Pharma Ingredients, Biotech, and Custom Synthesis. Since 2018, he has been serving as the Chief Mentoring Officer of Cadila Pharmaceuticals and as Whole-Time Director of CPL Pharma Pvt. Ltd, where he provides strategic, business, and operational leadership to drive growth and transformational change. With more than two decades of collaboration with global innovators and multinationals in the CDMO space, he is widely recognized for shaping partnerships and building differentiated capabilities.
He has held CXO and senior leadership roles across leading multinationals and Indian business houses, including Sandoz, Novartis, Laporte UK–Piramal JV, Dr. Reddy’s Laboratories, Jubilant Life Sciences, and Chemo Pharmaceuticals (Spain). His expertise covers global business expansion, operational excellence, Strategy and cross-cultural team integration.
A recipient of numerous national and international awards, Biswajit has served on the Board of ISPE of USA, chaired industry committees at the Confederation of Indian Industry (CII), and contributed as Vice-Chairperson of the Technical Committee of the Indian Pharmaceutical Congress. He also mentors emerging entrepreneurs through i-Hub, Government of Gujarat, Ministry of Education.
An alumnus of Calcutta University in Chemical Engineering and Chemistry (Hons.) and the Illustrious Alumni Award winner, Biswajit is a Fellow of the Institute of Engineers (FIE) and a Chartered Engineer. He has attended executive programs at leading business schools and is a frequent speaker at national and international forums.

Ramesh Choksi
Director

Ramesh Choksi
Director
Ramesh Choksi is a whole-time Director in Cadila Pharmaceuticals Ltd. and Director in CPL Biologicals Private Ltd., Casil Health Products Private Ltd., IRM Enterprises Private Ltd.
Ramesh Choksi has valuable experience spanning a myriad of industries such as pharmaceuticals, cement, engineering, finance and consumer products. He has been associated with Cadila for more than 23 years, working across various positions spanning finance, costing, production, management, distribution, domestic and international marketing. His expertise pertains establishing, conceptualizing and scaling up of plants for bulk production.
Ramesh Choksi holds a Master's degree in Commerce and is a Fellow Chartered Accountant of 1972 batch.

Amitabha Banerjee
Director

Amitabha Banerjee
Director
Amitabha Banerjee was an Executive Director of Cadila Pharmaceuticals limited, one of the largest privately held Pharmaceutical Company. Mr. Amitabha Banerjee holds a Post Graduate Degree in Commerce from the University of Calcutta, an Associate Member (ACMA) of the Institute of Cost Accountants of India and an Associate Member of International Institute of Management Sciences (AIMMS) Calcutta.
He has rich experience of working about 44 years, of which over 25 years with Cadila Pharmaceuticals Limited as a Member of Senior Management Team, where he held several key portfolios across the company and group including few strategic business units, overseas joint ventures and actively involved in several mergers and acquisitions. He was CFO of Cadila Pharmaceuticals Limited from 1999 - 2018 and was actively associated with International Business of the Company, all over the globe. He was also responsible for managing the affairs of CPL Biologicals Private Limited (Biological Business of Cadila Group) by holding position of Executive Director (Whole time Director) and CFO on the Board of CPL Biologicals Private limited, a Joint Venture between Cadila and Novavax Inc. USA. Since 2019, he played a Leadership role by monitoring and guiding the Formulation Manufacturing Operation, R&D, Regulatory affairs of the Company. He also had managed IT and HR operation of the company from time to time. Before joining Cadila Pharmaceuticals Limited, he worked with Tyre Industry (14 Years), Steels Industry (4 Years) and a Machine Manufacturing Company.
Mr. Amitabha Banerjee is also associated with IRM Energy Limited as Director since 2015.

Kamlesh Shah
Director

Kamlesh Shah
Director
Kamlesh Shah is a Cost Accountant and a LL.B with an extensive knowledge of working in Finance, Treasury and Banking Field. He is having a vast Industrial experience of around 30 years of working with leading multinational Pharmaceuticals Companies Like Lupin Limited and Cadila Pharmaceuticals Limited. Mr. Shah is Chief Financial Officer of Cadila Pharmaceuticals Limited, one of the largest privately held Pharmaceutical Company in India. He has been associated with Cadila Pharmaceuticals Limited for around 14 years. He is also holding Directorship in many Indian and Foreign Companies like CPL Pharmaceuticals Private Limited, IRM Private Limited and CPL Overseas Trading FZE.